Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-24 @ 2:52 PM
NCT ID:
NCT07033559
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥18 years old
* Self-reported generalised Myasthenia Gravis diagnosis confirmed by healthcare provider for ≥6 months
* Disease stability for ≥6 months (no hospitalisations, medication changes, or significant symptom worsening)
* English as first language
* Residence in US or UK
* Vision adequate for screen reading (with aid or correction if necessary)
* Access to internet-connected device with compatible browser and microphone
* Adequate internet connectivity (≥5 Mbps download, ≥3 Mbps upload)
* Ability to complete twice-daily assessments during specified time windows
* Signed electronic informed consent
Exclusion Criteria:
* Pure ocular Myasthenia Gravis
* Diagnosed mild cognitive impairment or dyslexia
* Speech or hearing impairments affecting voice recording
* Unable to provide credible diagnostic information (healthcare provider diagnosis, antibody test results, current medications)
* Major inconsistencies in reported medical history
* Unsigned informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07033559
Study Brief:
Protocol Section:
NCT07033559